Avadel Pharmaceuticals plc has appointed Kevin Kotler to the board, effective Dec. 11.
Kotler is the founder and portfolio manager of Broadfin Capital LLC and a director of BioDelivery Sciences International Inc.
Dublin-based Avadel Pharmaceuticals develops and commercializes pharmaceutical products primarily for treating urology and sleep medicines.